The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX
Official Title: A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX
Study ID: NCT05467176
Brief Summary: This is a multi-center, prospective, observational study of patients being treated with ORGOVYX. The goal of this study is to generate real-world evidence about the safety and effectiveness of ORGOVYX in patients with prostate cancer in routine clinical care and the clinical course during treatment with and following cessation of ORGOVYX.
Detailed Description: This prospective observational cohort study will be conducted in patients who are initiating treatment or have initiated treatment with ORGOVYX within the 1 month prior to the time of study enrollment and who remain on treatment at the time of enrollment. The decision to initiate treatment with ORGOVYX should be made prior to study enrollment. The study is designed to better understand the actual experience of patients with prostate cancer treated with ORGOVYX by collecting data on treatment patterns, adherence, and selective safety data. Additionally, a better understanding of the trajectory of patients with prostate cancer following cessation of ORGOVYX therapy will be gained by observing the clinical course of the disease, health outcomes, and health-related quality-of-life (HRQoL) in these patients.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Urology Centers of Alabama, Homewood, Alabama, United States
Urology Associates of Mobile, Mobile, Alabama, United States
Dignity Health, Phoenix, Arizona, United States
Arizona Urology Specialists, PLLC, Tucson, Arizona, United States
Arkansas Urology Research Center, Little Rock, Arkansas, United States
Urology Associates of Central California, Fresno, California, United States
Tower Urology, Los Angeles, California, United States
Tri Valley Urology, Murrieta, California, United States
Genesis Research LLC, San Diego, California, United States
Rocky Mountain Regional VA Medical Center, Aurora, Colorado, United States
The Urology Center of Colorado, Denver, Colorado, United States
Urology Associates, Lone Tree, Colorado, United States
The Stamford Hospital, Stamford, Connecticut, United States
Urologic Surgeons of Washington, Washington, District of Columbia, United States
Manatee Medical Research Institute, LLC, Bradenton, Florida, United States
Advanced Urology Institute, Daytona Beach, Florida, United States
Memorial Healthcare System, Hollywood, Florida, United States
SG Research LLC, Miami, Florida, United States
Florida Urology Partners, LLP, Tampa, Florida, United States
PRiSMS Group LLC, Arlington Heights, Illinois, United States
Associated Urological Specialists, Chicago Ridge, Illinois, United States
Northwestern University, Evanston, Illinois, United States
UroPartners Research, Glenview, Illinois, United States
Comprehensive Urologic Care, Lake Barrington, Illinois, United States
Advanced Urology Associates, New Lenox, Illinois, United States
Urology of Indiana, Carmel, Indiana, United States
Urologic Specialists of Northwest Indiana, Merrillville, Indiana, United States
University of Kansas Medical Center, Kansas City, Kansas, United States
Wichita Urology Group, P.A., Wichita, Kansas, United States
Southern Urology, Lafayette, Louisiana, United States
Chesapeake Urology Associates, Baltimore, Maryland, United States
Minnesota Urology, Woodbury, Minnesota, United States
Specialty Clinical Research of St. Louis, Saint Louis, Missouri, United States
Summit Health | New Jersey Urology, Berkeley Heights, New Jersey, United States
AtlanticCare Cancer Institute, Egg Harbor Township, New Jersey, United States
The Valley Hospital, Paramus, New Jersey, United States
Regional Cancer Care Associates, Teaneck, New Jersey, United States
Crystal Run Healthcare, Middletown, New York, United States
Urologic Surgeons of Long Island, Mount Kisco, New York, United States
Associated Medical Professionals of NY, PLLC, Syracuse, New York, United States
DJL Clinical Research, PLLC, Charlotte, North Carolina, United States
Associated Urologist of North Carolina, Raleigh, North Carolina, United States
Clinical Inquest Center Ltd, Beavercreek, Ohio, United States
NEO Urology Associates, Inc., Boardman, Ohio, United States
University Hospitals, Cleveland, Ohio, United States
Central Ohio Urology Group, Gahanna, Ohio, United States
Premier Clinical Research LLC dba STAT Research, Springboro, Ohio, United States
The University of Toledo, Toledo, Ohio, United States
Keystone Urology Specialist, Lancaster, Pennsylvania, United States
GU, Inc., Latrobe, Pennsylvania, United States
Carolina Urologic Research Center, LLC, Myrtle Beach, South Carolina, United States
Lowcountry Urology Clinics, North Charleston, South Carolina, United States
The Conrad Pearson Clinic, Germantown, Tennessee, United States
Urology Austin, Austin, Texas, United States
Hmu, Crc Llc, Houston, Texas, United States
New Horizon Medical Group, LLC, Houston, Texas, United States
Urology San Antonio, San Antonio, Texas, United States
The Urology Place, San Antonio, Texas, United States
Potomac Urology Center, PC, Alexandria, Virginia, United States
MedAtlantic, Richmond, Virginia, United States
Urology of Virginia, PLLC, Virginia Beach, Virginia, United States
Spokane Urology, P.S., Spokane, Washington, United States
Wisconsin Institute of Urology, Neenah, Wisconsin, United States
Name: Myovant Medical Monitor
Affiliation: Myovant Sciences
Role: STUDY_DIRECTOR